Nuvo Resources

Pregnancy is a delicate journey. Western medicine has evolved to provide the best possible care for pregnant moms – in hospitals and in clinics. But what happens during and after a missile attack when the facilities are not safe or accessible? What happens when pregnant moms who were already hospitalized for high-risk conditions such as preeclampsia or FGR, are suddenly told they must go home now because the hospital is under threat from missile attacks?

The answer sounds simple but was over a decade in the making: if you cannot bring the pregnant mom to the hospital, bring the hospital to the pregnant mom!

In Israel this was fast-tracked into reality after Oct 7. What has happened since and especially now during the current Israel crisis, is transforming pregnancy care with global implications that extend well beyond Israel’s present crisis.

Stage 1: Oct 8, 2023 – Moving Mountains, Cutting Through Bureaucracy

In the days following the horrific events of Oct 7, 2023 the urgency of the moment cut through the typical layers of healthcare bureaucracy. Sheba Beyond Maternity Care, a leading clinic in Israel, was ordered to clear out the maternity ward to make space in the hospital for the anticipated dramatic increase in soldier and civilian casualties. However, sending high-risk pregnant moms home without proper care could dramatically increase the risk of an adverse, and possibly life-threatening, outcome.

As fate would have it, Sheba Beyond was already collaborating in a clinical study with Nuvo, an innovative Israeli start-up that pioneered a groundbreaking wearable platform called INVU that was specifically designed to enable moms to monitor themselves and their baby-in-utero from anywhere, anytime, with medical data automatically sent to their physicians. The perfect solution in a time of need – as long as INVU could be approved by the Israel Health Ministry. Nuvo had good reason to be concerned about timing since it had just previously received FDA approval only after years of regulatory review.

This time it took just three weeks! The Israel Health Ministry fast-tracked the approval for the use of INVU to de-hospitalize high-risk patients based on the results of the already in progress clinical study being conducted by Sheba Beyond and Nuvo, along with the extensive clinical evidence that was used to receive the U.S. FDA approval.

Sheba Beyond has been de-hospitalizing high-risk pregnancies ever since and monitoring them remotely using INVU with exceptional results. Moms with high-risk pregnancies who would otherwise be confined to a hospital ward are instead receiving care from the comfort of their home or work with full medical oversight. The positive outcomes of Sheba Beyond’s experience has become the basis of significant ongoing studies, with initial results published in a major medical peer reviewed journal¹ as well as presented at a prominent medical conference².

Stage 2: June 13, 2025 – Innovating and Expanding

With the current heightened threat in Israel of missile attacks amplified by the direct missile hit on Soroka hospital in Southern Israel, it became immediately paramount to accelerate ‘hospital-at-home’ care for all departments. The next stage of remote pregnancy care is evolving in real-time and will have a global impact.

• Scaling Pregnancy Care – Remote pregnancy care is not limited by hospital rooms or in-hospital staffing resources. With the flexibility of INVU along with Sheba Beyond’s existing Command-and-Control center, Sheba Beyond can manage pregnancies for its own de-hospitalized pregnant moms and even support those de-hospitalized from other hospitals.
• Replicating Sheba’s Remote Pregnancy Command & Control Center (C&C) – Sheba Beyond has been gracious in offering other hospitals in Israel the opportunity to learn and replicate its remote pregnancy care Command & Control setup and protocol. A single nurse in a Command & Control center can remotely monitor multiple times the number of pregnancies that an in-hospital nurse can manage in person.
• Ambulatory Service Care – In many cases where a pregnant mom is concerned about the health of her in-utero baby that would typically lead to an emergency room visit, she can instead receive an in-home ambulatory service checkup with INVU. If warranted, the C&C physician can immediately enroll her into a remote pregnancy care protocol for a period of time or for the remainder of her pregnancy.

U.S. Impact

Sheba Beyond serves as a blueprint for the U.S. to also provide ‘hospital-at-home’ pregnancy care that could solve major issues in the U.S. healthcare system. Expanded use of remote non-stress tests (NSTs), as facilitated by INVU (which is FDA approved and already in use in the U.S.), can deliver significant benefits across cost, access, and clinical outcomes.

• ‍Avoiding Unscheduled Emergency Room Visits: A large proportion of OB emergency department (OB-ED) visits are for routine monitoring such as NSTs (Non-Stress Tests) rather than emergent issues. Studies have shown that up to 40% of OB-ED visits are avoidable and often tied to concerns that could be addressed through remote monitoring³. By enabling patients to perform NSTs using INVU from home with real-time physician oversight, these visits can be reduced, saving both patients and hospitals time and resources⁴.
• De-hospitalizing Moms for Routine NSTs (Non-Stress Tests): In many hospitals, pregnant women — especially those with high-risk conditions such as preeclampsia or fetal growth restriction — are admitted solely for daily or twice-daily NSTs. A retrospective analysis by U.S. health systems revealed that up to 25% of maternal in-patient days for high-risk pregnancies were primarily due to the need for frequent fetal monitoring5. Remote NSTs using INVU allow these mothers to receive the same level of oversight at home, improving comfort and significantly lowering hospitalization costs, which average $2,500 to $3,500 per day⁶.
• Expanding Access in Rural and Underserved Areas: More than 2.2 million women in the U.S. live in maternity care deserts, defined as counties with no hospital o[ering obstetric care and no OB providers⁷. Remote monitoring using INVU by Nuvo addresses this gap by conveniently bringing care directly to pregnant moms regardless of their location. Early pilot programs using remote NST technology demonstrated a 30% increase in timely interventions for fetal distress and maternal hypertension, as well as higher maternal satisfaction scores, particularly among those who would otherwise need to travel long distances for care⁸.‍
• Cost Reduction and Reimbursement Trends: Medicaid and private insurers are increasingly supporting telehealth and remote patient monitoring. Preliminary models show that substituting in-person NSTs with remote equivalents could reduce per-patient prenatal costs by up to $1,200, especially when integrated into value-based maternity care bundles⁹. Health systems piloting remote NSTs also report improved provider efficiency: a single tele-nurse can manage 3–5 times more patients than an in-hospital monitoring setup¹⁰.‍

Benefits of Ambulatory Service-Provided Spot NST Checks: Incorporating ambulatory services equipped with INVUs mobile NST capabilities provides a critical bridge between hospital care and remote monitoring. When a pregnant woman experiences symptoms or concerns, an on-the-spot INVU NST check performed by an ambulance-based team can rapidly assess fetal well-being and maternal status. This model offers several key benefits:‍

• Rapid Response Without ER Admission: Many low-risk but concerning symptoms lead to precautionary hospital visits. Mobile NSTs using INVU can reduce unnecessary ER congestion while still providing essential diagnostic reassurance¹¹.
• Early Detection of Complications: Field-based NST checks enable earlier detection of fetal heart rate abnormalities or signs of preterm labor, prompting timely escalation to hospital care only when necessary.
• Integration with Remote Care Protocols: If appropriate, a pregnant mom can be enrolled using INVU into a remote monitoring program directly from the point of contact, minimizing disruption and improving continuity of care.
• Cost Savings and Efficiency: Reduces use of hospital transport and labor while allowing clinicians to focus on critical in-facility care. For many systems, this model can lower overall maternity costs by decreasing non-urgent ED utilization¹².

Using INVU by Nuvo for remote pregnancy monitoring can enhance flexibility and safety while reinforcing the shift to patient-centered, digitally enabled prenatal care.

Call to Action

Israel is widely recognized and admired for its military capability and achievements in cybersecurity. Israel deserves an equal spotlight for groundbreaking innovation that helps “give life a better beginning”. What happens during pregnancy can affect a child’s health for the rest of their life¹³. A healthy pregnancy lays the foundation for a healthier life, not just for the baby, but for the mother too¹⁴.

Here is how you can help:

Amplify This Story on Social Media

Share the link to this story: www.nuvocares.com/resources/from-war-zone-to-living-rooms-israeli-innovation-redefines-pregnancy-care-at-home

Share other Sheba Beyond – Nuvo links:

• https://www.nuvocares.com/resources/sheba-medical-centercollaborates-with-nuvo-intl-group-to-develop-advanced-ai-poweredremote-prenatal-care-solutions
• https://www.nuvocares.com/resources/sheba-medical-center-andnuvo-group-expand-prenatal-care-beyond-the-hospital-during-crisis
• https://sheba-global.com/how-ai-and-remote-monitoring-arereshaping-maternal-health/
• https://sheba-global.com/sheba-beyonds-breakthrough-in-remotepregnancy-monitoring/

Post in social media sites, start a conversation, ask a question, invite feedback:

• Reddit: r/BabyBumps, r/Pregnant, r/Mommit
• Facebook Groups: “Due in 2025,” “First-Time Moms,” “Pregnancy Support”
• WhatsApp / Telegram: Local parent/mom groups

Follow, like, comment, and reshare Nuvo on:

• Instagram: https://www.instagram.com/nuvocares
• Facebook: https://www.facebook.com/NuvoCares
• LinkedIn: https://www.linkedin.com/company/nuvo-cares/

Tag Nuvo on:

• Instagram: @nuvocares
• Facebook: @nuvocares
• LinkedIn: https://www.linkedin.com/company/nuvo-cares/

⁠Tag friends who are pregnant, work in healthcare, or care about Israeli innovation

Consider Donating to Sheba Beyond Maternity Care

• Support the expansion of Sheba Beyond’s Maternity Care through a donation by contacting its head: Dr Avi Tsur.

Considering Remote Pregnancy Monitoring

• For more information about Nuvo contact us

‍

FOOTNOTES:

1 Link: https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.16148

2 Link: https://www.nuvocares.com/resources/nuvo-team-collaborators-at-smfm-2025-showcasingadvances-in-remote-pregnancy-monitoring

3 Kozhimannil, K.B., et al. (2014). "Maternal hospital-based utilization in the weeks after childbirth." Journal of Women's Health, 23(7), 587–592. Link: https://doi.org/10.1089/jwh.2013.4560

4 Pflugeisen, B.M., McCarren, C., Poore, S., Carlile, M., & Schroeder, R. (2016). “Virtual visits and patient centered care: Results of a patient survey and observational study.” Journal of Telemedicine and Telecare, 22(4), 238–242. Link: https://doi.org/10.1177/1357633X15586690

5 Smith, G.C., et al. (2011). “Indications for prolonged maternal hospitalization.” Obstetrics & Gynecology, 117(2), 398–403. Link: https://journals.lww.com/greenjournal/Fulltext/2011/02000/

6 Agency for Healthcare Research and Quality (AHRQ). “Healthcare Cost and Utilization Project (HCUP).” Link: https://www.hcup-us.ahrq.gov

7 March of Dimes. (2022). “Nowhere to Go: Maternity Care Deserts Across the U.S.” Link: https://www.marchofdimes.org/research/maternity-care-deserts-report.aspx

8 Marko, K.I., et al. (2019). “Remote prenatal care monitoring: A prospective pilot study of maternal and fetal outcomes.” Telemedicine and e-Health, 25(6), 489–494. Link: https://doi.org/10.1089/tmj.2018.0055

9 Deloitte Insights. (2020). “Digitizing pregnancy care: Using technology to improve maternal outcomes.” Link: https://www2.deloitte.com/insights/us/en/industry/health-care/technology-and-pregnancy-care.html

10 Chen, M., et al. (2022). “Telehealth monitoring for high-risk pregnancies: A review of outcomes and implementation.” JMIR mHealth and uHealth, 10(3): e25520. Link: https://mhealth.jmir.org/2022/3/e25520

11 Satpathy, H.K., et al. (2015). “Mobile health technology for pregnancy monitoring in underserved communities.” Journal of Perinatology, 35(11), 938–943.

Link: https://doi.org/10.1038/jp.2015.95

12 Peterson, E., Davis, N., & Dick, A. (2021). “Community paramedicine in maternal care: Opportunities and outcomes.” Health AEairs Blog. Link: https://www.healthalairs.org/do/10.1377/forefront.20210721.479175/

13 Barker, D.J.P. (1990). The fetal and infant origins of adult disease. BMJ, 301(6761), 1111. https://doi.org/10.1136/bmj.301.6761.1111

14 Hanson, M.A., & Gluckman, P.D. (2014). Early developmental conditioning of later health and disease: Physiology or pathophysiology? Physiological Reviews, 94(4), 1027–1076. https://doi.org/10.1152/physrev.00029.2013

‍

‍

Sheba Medical Center is at the forefront of the AI revolution, using new technologies to ensure healthy childbirth. Doctor Avi Tsur, director of Women’s Health Innovation at ARC-Sheba, is using data from Nuvo’s remote fetal monitoring solution in high risk pregnancies to identify and treat major complications like preeclampsia or fetal growth restriction—all before they can become major crises.

Nuvo is honored to be a part of this groundbreaking program that is changing the status quo in pregnancy care. These innovations are a great example of Nuvo's mission to give life a better beginning and we look forward to the resulting improvement women's healthcare delivery and pregnancy outcomes. This is also a great example of the Sheba/Nuvo collaboration announced earlier this year. Check out more detail on our strategic partnership here.

‍

Nuvo is pleased to announce the availability of INVU™ remote pregnancy monitoring platform at TLC Perinatal, one of the DC-area's premier maternal‑fetal medicine practices lead by Dr. Richie Broth. Together, the organizations will offer physician‑prescribed, remote NSTs to expectant patients cared for at TLC Perinatal’s offices in Silver Spring and Germantown, Maryland.

Advancing Care with Remote NSTs

The INVU platform combines a lightweight, wearable sensor band with AI analytics to capture fetal heart rate, maternal heart rate, and uterine activity in real time. Clinicians receive a full NST report through the existing electronic workflow, enabling timely, data‑driven decision making without requiring the patient to be physically present in the doctor’s office.

This partnership with TLC Perinatal marks a significant step toward expanding access to modern, patient-centric pregnancy care, reducing the need for frequent in-office visits while ensuring continuous medical oversight for both mother and baby.

Benefits of INVU by Nuvo at TLC Perinatal

For Patients:

• Greater Convenience – Complete clinically validated NSTs from home, reducing travel, time away from work, and childcare challenges.
• Continuity of Care – High‑risk patients (e.g., gestational diabetes, hypertension, IUGR) receive the recommended monitoring frequency without added burdens.
• Comfort & Reassurance – A soft, cable‑free wearable allows mothers to rest in their preferred environment while hearing real‑time feedback about their baby’s well‑being.

For Providers:

• Operational Efficiency – Reclaim in‑office capacity for patients who require face‑to‑face assessments while maintaining full oversight of remotely monitored pregnancies.
• Actionable Data – INVU transmits secure, high‑resolution waveforms and trend data directly into the TLC Perinatal workflow for rapid review and documentation.
• Clinical Confidence – FDA‑cleared technology with published validation studies supports evidence‑based decision‑making and regulatory compliance.

‍

Now Available at TLC Perinatal in both Maryland Offices

📍Silver Spring Office - 10801 Lockwood Drive, Suite 300, Silver Spring, MD 20901

📍Germantown Office - 12800 Middlebrook Road Suite 410, Germantown, MD 20874

‍

A Shared Commitment to Maternal‑Fetal Health

Nuvo and Dr. Broth are dedicated to modernizing prenatal care through innovative technology, rigorous clinical oversight, and patient‑centric services. By extending high‑quality monitoring beyond the clinic walls, the partnership aims to improve outcomes, optimize resources, and deliver a more compassionate experience for families across the Washington, DC metropolitan area.

Learn more about TLC Perinatal’s comprehensive offerings at tlcperinatal.com/cutting-edge-care

A team from Sheba Medical Center is presenting a poster titled "Empowering High-Risk Pregnant Women: A New Hybrid Model for Hospital at Home" at the World Hospital at Home Congress, taking place March 27–29, 2025, at the Austria Center Vienna (ACV), Bruno-Kreisky-Platz 1, 1220 Wien, Austria. The work introduces a hybrid maternal-fetal care model integrating remote monitoring with in-clinic assessments for high-risk pregnancies.

The study highlights the use of INVU™ by Nuvo to support remote non-stress testing and enhance care for women with high-risk pregnancies, improving patient adherence and reducing visit time.

Authored by Nirit Putievsky Pilosof, Rakefet Yoeli-Ullman, Esther Galler, Galia Barkai, Eyal Zimlichman, and Abraham Tsur, the poster demonstrates Sheba's ongoing work in maternal care innovation and Nuvo's role in enabling remote pregnancy monitoring.

‍

‍

‍

Nuvo is pleased to announce its partnership with MFM Associates, a leading maternal-fetal medicine practice in New York City, to bring INVU by Nuvo to expectant mothers across the region. This collaboration enables patients at MFM Associates’ New York City offices to access FDA-cleared remote Non-Stress Tests (NSTs), enhancing pregnancy monitoring with advanced, physician-prescribed technology. The partnership is particularly valuable for high-risk pregnancies during the third trimester, improving access to essential maternal-fetal care for patients in the tri-state area, including Connecticut (CT), New York (NY), and New Jersey (NJ).

Expanding Access to Remote Pregnancy Monitoring in the Tri-State Area

INVU by Nuvo is a clinically validated, wearable maternal-fetal monitoring platform that allows for remote, non-invasive tracking of fetal heart rate, maternal heart rate, and uterine activity. This technology is particularly critical for high-risk pregnancies in the third trimester, where frequent monitoring is necessary to monitor fetal health.

This partnership with MFM Associates marks a significant step toward expanding access to modern, patient-centric pregnancy care, reducing the need for frequent in-office visits while ensuring continuous medical oversight for both mother and baby.

Benefits of INVU by Nuvo at MFM Associates

✔ Convenient, remote Non-Stress Tests (NSTs) from home

✔ Critical monitoring for high-risk pregnancies during the third trimester

✔ Real-time data transmission for physician review

✔ Optimized care for conditions like gestational diabetes, hypertension, and IUGR

✔ Seamless integration into MFM Associates’ clinical workflow

Now Available at MFM Associates in New York City

📍 East Side Office – 70 East 90th Street, New York, NY 10128

This partnership reflects Nuvo’s ongoing commitment to advancing maternal-fetal medicine through innovation, technology, and strategic collaborations with leading healthcare providers.

Learn more at https://www.mfmnyc.com/pregnancy-care/invu-by-nuvo/

‍

RAMAT GAN, Israel – February 24, 2025 – ARC, the global health innovation engine and transformation arm of world-leading hospital Sheba Medical Center,  announced today a collaboration with Nuvo Intl. Group Inc. (Nuvo), a pioneer in remote pregnancy monitoring.Under the partnership, ARC and Nuvo will develop advanced AI-driven solutions that enhance clinical decision-making, improve early detection of pregnancy complications, and redefine the quality of continuous pregnancy monitoring, leading to improved maternal and fetal outcomes.

The collaboration will createAI-based modules that equip clinicians with advanced decision-support tools, enhance diagnostic capabilities, and enable early intervention. Additionally, population health analysis will be conducted to improve the quality of prenatal care in the community.

Nuvo’s remote monitoring solution enables expectant mothers to track their pregnancy conveniently from home, the workplace, or anywhere else, significantly improving the prenatal care experience and pregnancy outcomes. Under the direction of Dr. Avi Tsur, OB/GYN and high-risk pregnancy expert and Director of the Women’s HealthInnovation Center at Sheba Beyond, Sheba Medical Center’s virtual hospital, the collaboration will integrate medical research with Nuvo’s cutting-edge technology.

This agreement is part ofSheba's commitment to becoming one of the world’s first fully-integrated AI hospitals. Through ARC, Sheba is transforming healthcare by using AI to enhance patient care, diagnostics, and treatment personalization. As a leader in AI health tech, Sheba collaborates with top institutions like the Mayo Clinic to integrate advanced AI solutions across its departments, positioning itself at the forefront of medical innovation.

Prof. Eyal Zimlichman, Chief Transformation and Innovation Officer and Director of ARC at Sheba Medical Center, said: “Our partnership with Nuvo represents the future of pregnancy care. Integrating AI-powered solutions into routine prenatal monitoring not only enhances pregnancy outcomes but also demonstrates how technology can revolutionize healthcare worldwide.”

Laurence Klein, CEO of Nuvo Intl Group Inc., said: “We are excited to embark on this collaborative commercial and research partnership with Sheba’s ARC program, predicated on innovative, AI-driven modules powered by the INVU platform. Sheba ARC and ShebaBeyond’s global leadership in advancing remote and hybrid pregnancy care is invaluable, and we look forward to driving meaningful transformation together.”

About ARC

ARC, founded in 2019, is driving the redesign of global healthcare through a structured approach to innovation to equip all parts of the health ecosystem with the tools and resources to advance healthcare delivery and improve outcomes. Through ARC’s continuous pipeline of innovation, ability to facilitate large-scale transformation, access to leading health organizations, and ability to drive economic growth and development, ARC equips all player types in the ecosystem to transform global health. For more information, visit: https://arcinnovation.org

About Sheba Medical Center

The largest and most comprehensive medical center in the Middle East, Sheba Medical Center, Tel Hashomer, is generating global impact through its medical care, research, and healthcare transformation. Sheba’s City of Health boasts acute-care, rehabilitation, children’s, cancer, and geriatric hospitals, research and innovation hubs, a medical simulation center, and a center for disaster response on one comprehensive campus in the center of Israel. Sheba serves as a true hospital without borders, welcoming users and healthcare professionals from all over the world and consistently providing the highest-level medical care to all in need. Sheba has been ranked a World’s Best Hospital by Newsweek six years in a row (2019–2024). For more information, visit: https://sheba-global.com/

About Nuvo Intl. Group

Nuvo is leading a transformation in pregnancy care by providing clinicians and expectant mothers with access to medically-necessary remote pregnancy monitoring anytime, anywhere. Nuvo’s INVU™ platform is an FDA-and CE-cleared remote pregnancy monitoring and management system. It enables the delivery of remote non-stress tests (NSTs) and maternal and fetal heart rate monitoring while pioneering new data-driven personalized pathways that Nuvo believes can improve future health outcomes. INVU is being used by leading health providers and research institutions across the US and Israel. Nuvo plans to continue to expand the footprint of sales in the US and Israel to provide remote access and insights not previously deemed possible, while preparing for its market entry into Europe. Nuvo is led by a diverse team of experienced business, medical, and technology leaders, united in the mission of breaking down barriers to pregnancy care to give every life abetter beginning. For more information and complete indications, contraindications, warnings and precautions, and instructions for use, visit www.nuvocares.com

‍

The information contained in this press release is for informational purposes only and is not intended to serve as financial, legal, or investment advice. The content provided herein is based on current data as of the date of publication and is subject to change without notice.  This information may contain forward-looking statements, which include but are not limited to projections, plans, objectives, and future performance or assumptions underlying such statements. These statements are inherently uncertain and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied herein. Nuvo Intl. Group Inc. does not guarantee the accuracy, completeness, or timeliness of the information provided and expressly disclaims any liability for errors or omissions. Certain information has been provided by third-party sources and, although believed to be reliable, it has not been independently verified and its accuracy or completeness cannot be guaranteed.  Past performance is not indicative of future results. This information does not constitute an offer to sell or a solicitation to buy any securities or other financial instruments.

‍

Nuvo was honored to participate in the Society for Maternal-Fetal Medicine (SMFM) 2025 Pregnancy Meeting, held from January 27 to February 1, 2025, at the Gaylord Rockies Resort in Denver, Colorado. The conference remains a pivotal event in maternal-fetal medicine, bringing together experts in high-risk pregnancies to discuss cutting-edge advancements in maternal and fetal care.

Throughout the week, Nuvo enjoyed reconnecting with long-time colleagues and forging new relationships with MFMs, partners, and researchers. A prominent theme at SMFM 2025 was the continued growth of remote pregnancy monitoring, an area in which Nuvo is pioneering innovative solutions.

Remote Pregnancy Monitoring at SMFM 2025

Dr. Nadav Schwartz held a dynamic poster presentation on "Empowering Patients to Conduct NSTs from Home", showcasing real-world data on over 2,000 remote NST sessions using Nuvo technology. The session highlighted the high at-home fetal monitoring success rates, demonstrating its potential to improve accessibility and patient outcomes. Special recognition goes to Nuvo's Dr. Amit Reches and Barak Laish for their dedication and contributions to this research.

Our esteemed partners at Philips attracted a large audience for their Learning Lunch session, "Obstetric Innovation that Transcends Care Settings." The discussion, led by Dr. Richie Broth, Dr. Sina Haeri, and Dr. Michael Ruma, provided insights into how remote pregnancy monitoring transforms prenatal care. The speakers covered advancements in remote fetal non-stress testing (NST), blood pressure monitoring, and glucose tracking, emphasizing how these technologies reshape obstetric care.

Obstetric Innovation & Scientific Forums

Nuvo was also thrilled to engage in the Scientific Forum on Obstetric Innovation, chaired by Dr. Adam Lewkowitz and Dr. Alisse Hauspurg. During the session, Dr. Richie Broth sparked an engaging discussion on remote fetal monitoring, addressing its benefits, challenges, and lessons learned from real-world applications. Attendees gained valuable insights into how remote NSTs can enhance clinical decision-making and improve patient adherence.

For those interested, Dr. Broth’s presentation slides are available for download HERE.

Dedicated Sessions on Remote Pregnancy Monitoring

Several additional sessions at SMFM 2025 explored various aspects of remote pregnancy monitoring (RPM):

• Dr. Christina Yarrington from the University of New Mexico led a session on "Remote Blood Pressure Monitoring (RPM)," emphasizing the importance of RPM in detecting and managing hypertensive disorders during pregnancy.
• A compelling poster presentation, "Perinatal Outcomes Following Implementation of a Remote Patient Monitoring Program for Hypertensive Disorders in Pregnancy," outlined the tangible benefits of RPM programs in improving maternal and fetal health outcomes.

Looking Ahead‍

SMFM 2025 reinforced the growing importance of remote pregnancy monitoring in modern maternal-fetal care. The enthusiasm and engagement from healthcare providers, researchers, and industry partners demonstrated the medical community's readiness to embrace innovative solutions that enhance patient care and accessibility. Nuvo remains committed to advancing remote pregnancy monitoring technology and looks forward to continuing our collaborations with healthcare providers and partners to improve maternal and fetal health outcomes worldwide. For more information about Nuvo's remote pregnancy monitoring solutions or to discuss potential partnerships, don't hesitate to get in touch with our team here.

The study, conducted at Sheba Beyond, Sheba Medical Center, Tel Hashomer virtual hospital, showcased the successful implementation of INVU™ alongside other digital health technologies in a comprehensive remote monitoring solution for gestational diabetes. 

Technology Integration Partners:

• NUVO (INVU™): Provided remote fetal monitoring capabilities enabling real-time professional interpretation of non-stress tests
• PulseNmore: Supplied remote ultrasound technology for measuring amniotic fluid maximal vertical pocket, enabling complete modified biophysical profile assessment from home
• Healthy.io: Delivered digital urinalysis technology for remote monitoring of protein levels and maternal health indicators
• Datos Health: Provided the digital platform for monitoring vital signs and glycemic control.

The integrated solution enabled:

• Remote non-stress testing with real-time professional interpretation
• Home-based fetal surveillance
• Continuous maternal health monitoring
• Digital glucose tracking and diabetes management
• Remote urinalysis and vital signs monitoring
• Comprehensive virtual care visits
• Integration with electronic health records

The study validated INVU's effectiveness in managing various high-risk pregnancy conditions, including:

• Gestational diabetes (both A1GD and A2GD)
• Pregnancies requiring antepartum fetal surveillance
• Cases needing regular non-stress tests
• Conditions requiring a modified biophysical profile
• High-risk pregnancies at or beyond 32 weeks gestation

The research team achieved a remarkable 97.4% success rate in completing remote maternal-fetal assessments, with visit durations reduced by nearly two-thirds compared to in-clinic appointments. Clinical outcomes were notably positive, with high patient satisfaction scores (6.6 out of 7) and improved adherence to glucose monitoring protocols during the hybrid care. The research demonstrated that INVU can be effectively integrated into a broader remote care ecosystem, providing comprehensive care for maternal hypertensive disorders, fetal growth monitoring, and high-risk pregnancy surveillance.

‍
This successful integration demonstrates INVU's pivotal role in the future of maternal-fetal medicine, particularly in managing complex pregnancies requiring regular monitoring and assessment. Healthcare providers looking to implement comprehensive remote care programs for maternal-fetal care can benefit from INVU's proven platform.

‍
Publication Details:  Authors: Michal Axelrod, Hila Lahav Ezra, Esther Galler, Omer Nir, Keren Ofir, Galia Barkai, Eyal Sivan, Shali Mazaki-Tovi, Abraham Tsur, "Hybrid Remote and In-Clinic Maternal-Fetal Surveillance for Women with Gestational Diabetes: A Prospective Pilot Study" Journal: International Journal of Gynecology & Obstetrics Publication.  

This was originally published in the International Journal of Gynecology & Obstetrics here.

‍

Objective

This study explores a hybrid approach to maternal-fetal care for gestational diabetes (GD), integrating virtual visits seamlessly with in-clinic assessments. We assessed the feasibility, time efficiency, patient satisfaction, and clinical outcomes to facilitate wider adoption of maternal-fetal telemedicine.

Methods

We conducted a 4-week prospective study involving 20 women with GD at ≥32 weeks of pregnancy, alternating between remote and in-clinic weekly visits. Remote assessments began with women self-measuring vital signs and using a digital urine dipstick. The remote encounter started with a midwife performing anamnesis and remotely connecting women to the fetal nonstress test. A physician concluded the meeting with remote sonographic assessment of amniotic fluid maximal vertical pocket that together with the nonstress test provided the modified biophysical assessment as well as a video encounter and ongoing glycemic control assessment. We assessed the feasibility of remote visits, compared visit durations, evaluated women's satisfaction using the Telehealth Usability Questionnaire, examined glucose documentation adherence during hybrid care compared with the following period until birth, and assessed GD-related clinical outcomes.

Results

Remote visits had a success rate of 97.4% (38 of 39), with significantly shorter durations compared with in-clinic visits (median 59.0 min vs. 159.0 min, P < 0.001). Women expressed high satisfaction (6.6 of 7), and adherence with recording fasting glucose values during the study period was significantly higher than the following period until birth (92.2% vs. 61.8%, P = 0.001). Notably, none required induction of labor for glycemic control imbalance, and there were no cases of macrosomia, shoulder dystocia, or neonatal hypoglycemia.

Conclusion

The hybrid approach to maternal-fetal care for GD demonstrated feasibility, safety, time efficiency, improved patient satisfaction, and enhanced glycemic control adherence.

‍